Menopause: Difference between revisions
No edit summary |
No edit summary |
||
Line 25: | Line 25: | ||
| | | | ||
* Epithelial lining of the vagina and urethra are estrogen-dependent tissues, and estrogen deficiency leads to thinning of the vaginal epithelium, this results in vaginal atrophy, which leads to dryness, itching, and often [[Dyspareunia|dyspareunia.]]<ref name=":3" /> | * Epithelial lining of the vagina and urethra are estrogen-dependent tissues, and estrogen deficiency leads to thinning of the vaginal epithelium, this results in vaginal atrophy, which leads to dryness, itching, and often [[Dyspareunia|dyspareunia.]]<ref name=":3" /> | ||
* One of the earliest signs of estrogen insufficiency is noticed when there is a decrease in vaginal lubrication upon sexual arousal | |||
|- | |- | ||
|Sexual function | |Sexual function |
Revision as of 22:24, 24 April 2019
This article is currently under review and may not be up to date. Please come back soon to see the finished work! (24/04/2019)
Definition[edit | edit source]
Natural menopause occurs when there is a complete, or near complete, ovarian follicular depletion of a female's ovaries. This results in the end of her menstrual cycle for 12 months, which is retrospectively determined. It occurs at a median age of 51.4 years and menopause before the age of 40 years old is considered abnormal. The months and years leading up to this are called peri-menopause.[1]
Clinical Exam[edit | edit source]
Subjective:
Symptoms of menopause and peri-menopause:[2][3]
Symptoms | Information |
---|---|
Hot flashes |
|
Vaginal dryness |
|
Sexual function |
|
Mood symptoms | |
Sleep disturbances |
|
Joint pain | |
Cognitive changes | |
Irregular bleeding or spotting |
Longterm consequences of low estrogen
Health Concerns | Information |
---|---|
Bone loss | |
Cardiovascular disease | |
Dementia | |
Osteoarthritis | |
Body composition | |
Skin changes | |
Balance |
Objective:
Stages of Reproductive Aging Workshop (STRAW) staging system was developed from data from multiple longitudinal cohort studies. This system is considered the gold standard and includes criteria for the reproductive years, the menopausal transition, perimenopause, final menstrual period (FMP), and postmenopause based upon bleeding patterns, endocrine findings, and symptoms. The STRAW system is used mainly in research, however, it may be helpful in the clinical setting for patients and clinicians to assess fertility potential, contraceptive needs, and potential need for hormone therapy.[9]
Stage[9] | Signs/Symptoms[9] |
---|---|
Late reproductive years | May begin to notice changes in her menstrual cycle (ie. a shorter cycle) |
Early menopausal transition | This is marked by increased variability in menstrual cycle length |
Late menopausal transition | Marked by the occurrence of amenorrhea of 60 days or longer
Characterized by increased variability in cycle length, and extreme fluctuations in hormonal levels |
Early postmenopause period | Corresponds to the end of “perimenopause,” a term still in common usage that means the time around menopause |
Late postmenopause period | Symptoms of vaginal dryness and urogenital atrophy become increasingly prevalent at this time |
Management[edit | edit source]
Physiotherapy
It is important as healthcare providers, we are aware of the menopausal process and the symptoms that can come along with this period in a female's life. Many of the symptoms and health concerns discussed can have a negative impact on a women's health.
Issue | Intervention |
---|---|
Vaginal Dryness and/or Sexual Health |
|
Bone Loss |
|
Balance |
|
Medical
vaginal estrogen therapy for GSM
Resources[edit | edit source]
American College of Obstetricians and Gynecologists: Menopause Resource Overview
References[edit | edit source]
- ↑ The American College of Obstetricians and Gynecologists. Menopause: Resource Overview. Available from https://www.acog.org/Womens-Health/Menopause
- ↑ Burger HG. Unpredictable endocrinology of the menopause transition: clinical, diagnostic and management implications. Menopause international. 2011 Dec;17(4):153-4.
- ↑ Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause. 2008 Jul 1;15(4):603-12.
- ↑ 4.0 4.1 Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation. Obstetrics and Gynecology Clinics. 2011 Sep 1;38(3):489-501.
- ↑ Randolph JF, Sowers M, Bondarenko IV, Gold EB, Greendale GA. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms across the menopausal transition. Fertility and Sterility. 2004 Sep 1;82:S65.
- ↑ 6.0 6.1 Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. American journal of obstetrics and gynecology. 2016 Dec 1;215(6):704-11.
- ↑ Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Climacteric. 2014 Oct 1;17(5):557-63.
- ↑ Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003 Jan 1;10(1):19-28.
- ↑ 9.0 9.1 9.2 Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R, Sherman S, Sluss P, de Villiers T. Executive summary of the stages of reproductive aging workshop+ 10. Menopause. 2012 Apr 1;19(4):387-95.
- ↑ Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. The journal of sexual medicine. 2011 Feb 1;8(2):549-59.
- ↑ Howe TE, Shea B, Dawson LJ, Downie F, Murray A, Ross C, Harbour RT, Caldwell LM, Creed G. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane database of systematic reviews. 2011(7).